U.S., June 25 -- ClinicalTrials.gov registry received information related to the study (NCT07033013) titled 'A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS).' on June 13.
Brief Summary: Randomized, Double-Blind, Placebo-Controlled, Single-Center Clinical Study with a Run-in Baseline, Daily Diary Log, and Validated Questionnaires (Greene GCS) with Oral Dietary Supplement
Study Start Date: June 20
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DIETARY_SUPPLEMENT: Placebo
Placebo
DIETARY_SUPPLEMENT: Dietary Supplement with actives
Dietary supplement containing EstroG-100 and GABA
Recruitment...